The worlds #1 website for end of day & historical stock data
wide range of exchanges, data formats, tools and services
HISTORICAL DATA
SYMBOL LISTS
MEMBERSHIP
REGISTER
LOG IN
Toggle navigation
HOME
Home Page
Download
Symbol Lists
Quote & Chart
Symbol Changes
Splits
PRODUCTS & SERVICES
Membership Levels
Conversion Utility
Data Client
Historical Data
Fundamental Data
Commercial Feeds
Web Service
HOW TO
Advanced Get
AIQ
AMIBroker
EzyChart
MetaStock
OmniTrader
SuperCharts
TradeStation
SUPPORT
FAQ
Data Formats
Data Quality
Forgotten Password
Submit a Support Request
ABOUT
About Us
Contact Us
Terms & Conditions
Privacy Policy
Useful Links
MY ACCOUNT
Downloads
Account Details
Buy Historical Data
Billing History
Data Format
Daily Emails
Watchlists
NASDAQ, AGEN:
08 Aug 25 16:17
LAST:
4.810
CHANGE:
0.04
OPEN:
4.750
HIGH:
4.820
ASK:
3.730
VOLUME:
605.4K
CHG(%):
0.84
PREV:
4.760
LOW:
4.600
BID:
3.560
CHART
Period:
End of Day
1 Minute
5 Minute
10 Minute
15 Minute
30 Minute
Hourly
Weekly
Monthly
Yearly
RECENT END OF DAY PRICES
Date
Open
High
Low
Close
Volume
08 Aug 25
4.750
4.820
4.600
4.800
608.8K
07 Aug 25
4.800
4.880
4.650
4.760
626.7K
06 Aug 25
5.300
5.321
4.750
4.760
777.9K
05 Aug 25
5.390
5.430
5.090
5.290
527.7K
04 Aug 25
5.490
5.590
5.370
5.400
347.8K
01 Aug 25
5.500
5.630
5.340
5.360
269.1K
31 Jul 25
5.890
5.999
5.490
5.520
671.4K
30 Jul 25
5.820
6.215
5.820
5.900
469.9K
29 Jul 25
6.310
6.330
5.762
5.880
873.3K
28 Jul 25
6.000
6.580
5.900
6.350
1.23M
COMPANY PROFILE
Name:
About:
Antigenics Inc. (including its subsidiaries, also referred to in this Annual Report on Form 10-K as ?Antigenics?, the ?Company?, ?we?, ?us?, and ?our?) is a biotechnology company developing technologies and product candidates to treat cancers and infectious diseases, primarily based on immunological approaches. Our most advanced product candidate is Oncophage? (vitespen), a patient-specific therapeutic cancer vaccine candidate that has been tested, or is currently being tested, in several cancer indications, including in Phase 3 clinical trials for the treatment of renal cell carcinoma, the most common type of kidney cancer, and for metastatic melanoma. Oncophage has also been tested in Phase 1 and Phase 2 clinical trials in a range of indications and is currently being tested in a Phase 1/2 clinical trial in recurrent glioma, or brain cancer. ...
Sector:
Health Care
Industry:
Biotechnology: Biological Products (No Diagnostic Substances)
CUSIP:
037032109
CIK:
1098972
SYMBOL HISTORY
Purchase End of Day History
for this symbol from Feb 04, 2000
Purchase Intraday History
for this symbol from Feb 04, 2000
Add to Watchlist
ADD TO WATCHLIST
Please select which Watchlist you would like to add this symbol to:
Watchlist:
DOWNLOAD DATA
Download stock quote history quickly and easily in a variety of formats to suit your needs.
Exchange:
American Stock Exchange
Australian Securities Exchange
Chicago Futures Exchange
Cryptocurrencies
EUREX Futures Exchange
Euronext - Amsterdam
Euronext - Brussels
Euronext - Lisbon
Euronext - Oslo
Euronext - Paris
Foreign Exchange
Frankfurt Exchange
Global Indices
LIFFE Futures and Options
London Stock Exchange
Madrid Stock Exchange
Minneapolis Grain Exchange
Mutual Funds
NASDAQ Stock Exchange
National Stock Exchange of India
New York Board of Trade
New York Stock Exchange
OTC Bulletin Board
Shanghai Stock Exchange
Shenzhen Stock Exchange
Singapore Stock Exchange
Toronto Stock Exchange
Toronto Venture Exchange
Winnipeg Commodity Exchange
Format:
3F VIP Trading
Advanced Get ASCII
AGet ASCII
AIQ Trading Expert Pro
Ami Broker
Ami Broker with Names
Andromeda
ASCII (Intraday)
EzyCharts
FCharts
FCharts (Intraday)
MetaStock ASCII (7 column)
MetaStock ASCII (8 column)
Metastock ASCII (Intraday)
MetaStock ASCII with Names
Personal Stock Streamer
Quicken
SpiffyCharts
Spreadsheet (eg: Excel)
Standard CSV
Stock Screener Pro
SuperCharts ASCII
Wal Data Platinum
Windows on Wallstreet
Period:
End of Day
1 Minute Bars
5 Minute Bars
10 Minute Bars
15 Minute Bars
30 Minute Bars
60 Minute Bars
Zip file
Symbol:
Start Date:
End Date:
FUNDAMENTALS
P/E Ratio:
0.21
EPS Ratio:
29.61
PtB:
-0.47
PtS:
8.62
Shares:
27.42M
Market Cap:
131.87M
52wk range:
1.38 - 7.34
TECHNICALS
MA5:
5.00
MA20:
5.83
MA50:
5.25
MA200:
3.59
STO9:
0.85
RSI14:
22.32
WPR14:
-97.48
MTM14:
-1.32
ROC14:
0.78
Week High:
5.59
Week Low:
4.60
Month High:
7.34
Month Low:
4.60
Volatility:
49.43